Results 111 to 120 of about 120,872 (251)
A bayesian network model of proteins' association with promyelocytic leukemia (PML) nuclear bodies
The modularity that nuclear organization brings has the potential to explain the function of aggregates of proteins and RNA. Promyelocytic leukemia nuclear bodies are implicated in important regulatory processes.
Boden, Mikael +4 more
core +1 more source
Human surfactant protein D alters oxidative stress and HMGA1 expression to induce p53 apoptotic pathway in eosinophil leukemic cell line [PDF]
This article is made available through the Brunel Open Access Publishing Fund. Copyright: © 2013 Mahajan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use ...
Pandit Hrishikesh +46 more
core +1 more source
Arsenic trioxide (ATO) is able to selectively target and degrade the disease-causing PML::RARα (P/R) oncoprotein in acute promyelocytic leukemia (APL) for curing the disease.
Pei-Han Yu +4 more
doaj +1 more source
Background: The degradation of promyelocytic leukemia (PML) protein is regulated by phosphorylation-dependent manner. Results: The inhibition or knockdown of ERK2 increase PML expression level and decrease the interaction between PML and Pin1. Conclusion:
J. Lim, Yu Liu, Erin Reineke, H. Kao
semanticscholar +1 more source
The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis [PDF]
AbstractExpression of the PMLRARα fusion dominant‐negative oncogene in the epidermis of transgenic mice resulted in spontaneous skin tumors attributed to changes in both the PML and RAR pathways [Hansen et al., Cancer Res 2003; 63:5257–5265]. To determine the contribution of PML to skin tumor susceptibility, transgenic mice were generated on an FVB/N ...
Victoria M, Virador +10 more
openaire +2 more sources
The role of promyelocytic leukemia protein in genome maintenance [PDF]
Promyelocytic leukemia protein (PML) is a key component for a formation of the PML nuclear bodies (PML−NBs) in which PML forms a shell surrounding an inner core of this dynamic multiprotein komplex.
Kindlová, Martina
core
1. Network pharmacology identified Qingdainone as a key bioactive compound in RIF. 2. Molecular docking revealed strong binding affinities of Qingdainone to targets such as CCND1, CDK1, CDK4, CASP3 and CASP7. 3. Qingdainone interfered proliferation and apoptosis, and promoted differentiation, of ATRA‐sensitive and ‐resistant APL cells, such that ...
Pengcheng Xu +7 more
wiley +1 more source
Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter
Promyelocytic leukemia (Pml) protein is required for Oct4 gene expression and the maintenance of its open chromatin conformation in stem cells. In proliferating stem cells, Pml‐nuclear body, along with transcription factors TR2, steroidogenic factor 1 ...
Ya-Shan Chuang +6 more
semanticscholar +1 more source
Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein [PDF]
ABSTRACTThe interferon (IFN)-induced promyelocytic leukemia (PML) protein is specifically associated with nuclear bodies (NBs) whose functions are yet unknown. Two of the NB-associated proteins, PML and Sp100, are induced by IFN. Here we show that overexpression of PML and not Sp100 induces resistance to infections by vesicular stomatitis virus (VSV ...
M K, Chelbi-Alix +4 more
openaire +2 more sources
N‐acetyltransferase 10 (NAT10) catalyses N4‐acetylcytidine (ac4C) modification of PML pre‐mRNA, shifting splicing from the senescence‐promoting PML‐FL to the senescence‐inhibiting PML‐S isoform via SRSF1. This rejuvenates adipose‐derived stem cells (ADSCs) by reducing senescence markers and senescence‐associated secretory phenotype (SASP), thereby ...
Wuhan Wei +9 more
wiley +1 more source

